Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > COMMENTARY
COMMENTARY
- Number of Entrants into Market for Biosimilars Increases, But Barriers Are Still High
February 8, 2010
- New Pricing System to Make e-Detailing More Important
February 1, 2010
- Number of Holders of Designated Disease Treatment Beneficiary Certificate Up to 647,604
November 30, 2009
- Verify Acceptability of Prices before Revising Pricing Rule
November 30, 2009
- Pharmacology of Aging and Longevity: Looking for Anti-Aging Therapeutics （１）
November 2, 2009
- Pharmacology of Aging and Longevity: Looking for Anti-Aging Therapeutics （２）
November 2, 2009
- How Not to License a Drug into Japan
October 12, 2009
- TOPICS／Abbott Named One of the "Best Places to Launch a Career" by BusinessWeek
October 5, 2009
- NHI Drug Pricing System Reform Becomes Further Unpredictable Following Gov't Change
October 5, 2009
- COMMENTARY／Pharma Industry Watches New DPJ Administration with Both Anticipation and Concerns
September 21, 2009
- COMMENTARY／Will It Be Possible to Eliminate Use of Multiple Antipsychotics in Massive Doses?
September 14, 2009
- COMMENTARY／Establish Solid Criteria for Switching Ethical Drugs to OTC Status
September 14, 2009
- COMMENTARY／Korosho to Embark on Japanese Version of Sentinel Initiative
September 7, 2009
- COMMENTARY／Wholesalers Need to Analyze Causes of Their Failure
August 24, 2009
- COMMENTARY／Hisamitsu Aims at Growth by Fusing Its and Noven's Technologies
August 24, 2009
- COMMENTARY／Permitting MSs to Take MR Cert. Exam Offers New Business Opportunity to Wholesalers
August 3, 2009
- COMMENTARY／Fair Profits Are Essential to Spread Regenerative Medicine
August 3, 2009
- Hitech Drugs Open the Window to the Future- With Special Focus on Development and Marketing -(1)
July 20, 2009
- Hitech Drugs Open the Window to the Future- With Special Focus on Development and Marketing -(2)
July 20, 2009
- COMMENTARY／Global Pharmas Enhance Their Presence in Japan
July 13, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…